Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Canaan (CAN) Cash & Equivalents (2018 - 2025)

Canaan has reported Cash & Equivalents over the past 8 years, most recently at $80.8 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 16.28% to $80.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $80.8 million through Dec 2025, down 16.28% year-over-year, with the annual reading at $80.8 million for FY2025, 16.28% down from the prior year.
  • Cash & Equivalents was $80.8 million for Q4 2025 at Canaan, down from $119.2 billion in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $119.2 billion in Q3 2025 and troughed at $54739.0 in Q1 2024.
  • The 5-year median for Cash & Equivalents is $96.5 million (2024), against an average of $6.4 billion.
  • Year-over-year, Cash & Equivalents tumbled 99.98% in 2023 and then skyrocketed 165969.49% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $419.9 million in 2021, then plummeted by 76.31% to $99.4 million in 2022, then fell by 3.31% to $96.2 million in 2023, then rose by 0.35% to $96.5 million in 2024, then decreased by 16.28% to $80.8 million in 2025.
  • Per Business Quant, the three most recent readings for CAN's Cash & Equivalents are $80.8 million (Q4 2025), $119.2 billion (Q3 2025), and $65.9 million (Q2 2025).